Ignite Creation Date:
2025-12-24 @ 9:42 PM
Ignite Modification Date:
2025-12-30 @ 2:29 PM
Study NCT ID:
NCT03148132
Status:
COMPLETED
Last Update Posted:
2019-01-09
First Post:
2017-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
VEGF Concentrations After Intravitreal Bevacizumab vs Ranibizumab as a Treatment for Type 1 ROP
Sponsor:
Universidad Autonoma de San Luis PotosÃ
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-08-30
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-08
First Submit QC Date:
None
Study First Post Date:
2017-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-08
Last Update Post Date:
2019-01-09
Last Update Post Date Type:
ACTUAL